Cargando…

Retaining the structural integrity of disulfide bonds in diphtheria toxoid carrier protein is crucial for the effectiveness of glycoconjugate vaccine candidates

The introduction of glycoconjugate vaccines marks an important point in the fight against various infectious diseases. The covalent conjugation of relevant polysaccharide antigens to immunogenic carrier proteins enables the induction of a long-lasting and robust IgG antibody response, which is not o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carboni, Filippo, Kitowski, Annabel, Sorieul, Charlotte, Veggi, Daniele, Marques, Marta C., Oldrini, Davide, Balducci, Evita, Brogioni, Barbara, Del Bino, Linda, Corrado, Alessio, Angiolini, Francesca, Dello Iacono, Lucia, Margarit, Immaculada, Romano, Maria Rosaria, Bernardes, Gonçalo J. L., Adamo, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864718/ https://www.ncbi.nlm.nih.gov/pubmed/35310500 http://dx.doi.org/10.1039/d1sc01928g

Ejemplares similares

Structure‐Guided Design of a Group B Streptococcus Type III Synthetic Glycan–Conjugate Vaccine
por: Oldrini, Davide, et al.
Publicado: (2020)

THE PURIFICATION AND CONCENTRATION OF DIPHTHERIA TOXOID
por: Wadsworth, Augustus, et al.
Publicado: (1932)

Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates
por: Campisi, Edmondo, et al.
Publicado: (2021)

Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population
por: Yusoff, Ahmad Faudzi, et al.
Publicado: (2021)

Solution conformation and flexibility of capsular polysaccharides from Neisseria meningitidis and glycoconjugates with the tetanus toxoid protein
por: Abdelhameed, Ali Saber, et al.
Publicado: (2016)

Maternal vaccination with a type-III glycoconjugate protects mouse neonates against Group B Streptococcus intranasal infection
por: Chiarot, Emiliano, et al.
Publicado: (2021)

Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
por: Ammar, Hussam
Publicado: (2011)

Investigating preparation and characterisation of diphtheria toxoid‐loaded on sodium alginate nanoparticles
por: Aghamiri, Samira, et al.
Publicado: (2022)

IMMUNOCHEMICAL STUDIES OF ANTITOXIN PRODUCED IN NORMAL AND ALLERGIC INDIVIDUALS HYPERIMMUNIZED WITH DIPHTHERIA TOXOID : I. RELATIONSHIP OF SKIN SENSITIVITY TO PURIFIED DIPHTHERIA TOXOID TO THE PRESENCE OF CIRCULATING, NON-PRECIPITATING ANTITOXIN
por: Kuhns, William J., et al.
Publicado: (1952)

IMMUNOCHEMICAL STUDIES OF ANTITOXIN PRODUCED IN NORMAL AND ALLERGIC INDIVIDUALS HYPERIMMUNIZED WITH DIPHTHERIA TOXOID : I. RELATIONSHIP OF SKIN SENSITIVITY TO PURIFIED DIPHTHERIA TOXOID TO THE PRESENCE OF CIRCULATING, NON-PRECIPITATING ANTITOXIN
por: Kuhns, William J., et al.
Publicado: (1952)

Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance
por: Del Bino, Linda, et al.
Publicado: (2022)

Fighting Antibiotic-Resistant Klebsiella pneumoniae with “Sweet” Immune Targets
por: Adamo, Roberto, et al.
Publicado: (2018)

Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland
por: Zasada, Aleksandra A, et al.
Publicado: (2013)

2461. Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents
por: Myers, Tanya, et al.
Publicado: (2018)

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine
por: Baxter, Roger, et al.
Publicado: (2016)

Glycoconjugate vaccines: classic and novel approaches
por: Adamo, Roberto
Publicado: (2021)

Editorial: Glycoconjugates in vaccines and immunotherapeutics
por: Shivatare, Sachin, et al.
Publicado: (2022)

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
por: Havers, Fiona P., et al.
Publicado: (2020)

Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid
por: de Groot, Anne Marit, et al.
Publicado: (2017)

A glycoconjugate of Haemophilus influenzae Type b capsular polysaccharide with tetanus toxoid protein: hydrodynamic properties mainly influenced by the carbohydrate
por: Abdelhameed, Ali Saber, et al.
Publicado: (2016)

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012
por: Sawyer, Mark, et al.
Publicado: (2013)

Barriers to Receipt of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Among Mothers of Infants Aged <4 Months with Pertussis — California, 2016
por: New, Sarah, et al.
Publicado: (2018)

CELLULAR SITES OF SYNTHESIS OF RABBIT IMMUNOGLOBULINS DURING PRIMARY RESPONSE TO DIPHTHERIA TOXOID-FREUND'S ADJUVANT
por: Schoenberg, M. D., et al.
Publicado: (1965)

Microneedle-Based Transcutaneous Immunisation in Mice with N-Trimethyl Chitosan Adjuvanted Diphtheria Toxoid Formulations
por: Bal, Suzanne M., et al.
Publicado: (2010)

Pseudomonas aeruginosa PAO-1 Lipopolysaccharide-Diphtheria Toxoid Conjugate Vaccine: Preparation, Characterization and Immunogenicity
por: Najafzadeh, Faezeh, et al.
Publicado: (2015)

Immunogenicity comparison of conjugate vaccines composed of alginate and lipopolysaccharide of Pseudomonas aeruginosa bound to diphtheria toxoid
por: Najafzadeh, Faezeh, et al.
Publicado: (2014)

Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
por: Kumar, Vivek, et al.
Publicado: (2018)

Hoffmeister Series Ions Protect Diphtheria Toxoid from Structural Damages at Solvent/Water Interface
por: Namur, Jocimara A.M., et al.
Publicado: (2009)

Oxetane Grafts Installed Site‐Selectively on Native Disulfides to Enhance Protein Stability and Activity In Vivo
por: Martínez‐Sáez, Nuria, et al.
Publicado: (2017)

A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Korea
por: Park, Hee-Jin, et al.
Publicado: (2019)

Changes in TNF and IL-6 production after diphtheria toxoid vaccination: drug modulation of the cytokine levels
por: Pukhalsky, A. L., et al.
Publicado: (1996)

Transcutaneous Immunization Studies in Mice Using Diphtheria Toxoid-Loaded Vesicle Formulations and a Microneedle Array
por: Ding, Zhi, et al.
Publicado: (2010)

Cellobiose-coated poly (lactide-co-glycolide) particles loaded with diphtheria toxoid for per os immunization
por: Chudina, Tetiana, et al.
Publicado: (2015)

Coated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles
por: Du, Guangsheng, et al.
Publicado: (2018)

Cost of Delivering Tetanus Toxoid and Tetanus-Diphtheria Vaccination in Vietnam and the Budget Impact of Proposed Changes to the Schedule
por: Mai, Vu Quynh, et al.
Publicado: (2022)

Epitope Profiling of Diphtheria Toxoid Provides Enhanced Monitoring for Consistency Testing during Manufacturing Process Changes
por: Houy, Camille, et al.
Publicado: (2022)

Potential targets for next generation antimicrobial glycoconjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2018)

Polysaccharides’ Structures and Functions in Biofilm Architecture of Antimicrobial-Resistant (AMR) Pathogens
por: Balducci, Evita, et al.
Publicado: (2023)

Synthesis, characterization and immunological properties of Escherichia coli 0157:H7 lipopolysaccharide- diphtheria toxoid conjugate vaccine
por: Rokhsartalab-Azar, Shadi, et al.
Publicado: (2015)

Comparison of Immune Responses to Two Quadrivalent Meningococcal Conjugate Vaccines (CRM197 and Diphtheria Toxoid) in Healthy Adults
por: Kim, Han Wool, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cpeubt53fo6f0m7a3694sq48ce